The New York Times, July 11, 2017. Medical device makers might be able to delay reporting dangerous malfunctions to the FDA under a proposed agreement.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Eases Notice Requirement on More Than 1,000 Medical Devices
Bloomberg, July 10 2017: The FDA removed evidence requirements for over 1,000 moderate-risk medical devices. This has pleased AdvaMed and other companies but it means even less information for patients, and we agree that it could result in less safe medical devices.
Read More »New CDC Head Fitzgerald Peddled Controversial ‘Anti-Aging Medicine’ Before Leaving Private Practice
Forbes, July 9 2017: Dr. Brenda Fitzgerald, the new CDC director, previously promoted unproven anti-aging treatments, raising concerns about her commitment to science-based medicine. NCHR and other health experts question whether her qualifications align with the CDC’s mission to rely on credible scientific evidence for public health decisions.
Read More »Special Report: Many Expensive New Cancer Drugs Are Useless (or Worse)
Bottom Line, July 3 2017: Many new cancer drugs are costly but aren’t proven to help patients live longer or improve their quality of life. We and other experts worry that fast FDA approvals are based on questionable evidence. Some drugs have serious side effects and don’t improve survival, yet they remain on the market for years, harming patients and costing patients and our healthcare system billions of dollars.
Read More »Morcellator Cancer Reports Drop, Essure Reports Rise
Drugwatch, June 20, 2017:Reports of cancer that was spread by power morcellators have decreased, while injuries from Essure sterilization (permanent birth control) devices have increased. We join other experts who are concerned about FDA’s reporting system and emphasize our support of the Medical Device Safety Act, which would improve the safety of medical devices
Read More »